Frank Biondi - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Independent Director

Mr. Frank J. Biondi, Jr., is an Independent Director of Amgen Inc. Frank J. Biondi, Jr. has served as Senior Managing Director of WaterView Advisors LLC, an investment advisor organization, since 1999. Prior to WaterView Advisors, Mr. Biondi was the Chairman and Chief Executive Officer of Universal Studios, Inc. from 1996 to 1998, the President and Chief Executive Officer of Viacom, Inc. from 1987 to 1996, Executive Vice President of Entertainment Business Sector of The CocaCola Company and Chairman and Chief Executive Officer of CocaCola Television from 1985 to 1987, Chairman and Chief Executive Officer of Time Inc.s subsidiary Home Box Office, Inc. from 1982 to 1984, Vice President of Time Inc. from 1978 to 1984 and Assistant Treasurer of the Childrens Television Workshop from 1974 to 1978
Age: 70  Director Since 2002      
805 447-1010  www.amgen.com
Biondi was a director of Cablevision Systems Corporationrationration, a telecommunications, media and entertainment company, since 2005; Seagate Technology plc, a manufacturer of data storage products, since 2005, serving on its Compensation Committee and chairing its Finance Committee; and ViaSat, Inc., a provider of satellite and other wireless networking systems, since April 2015, serving on its Audit and Compensation and Human Resources Committees.

Frank Biondi Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Richard RelyeaQuintiles IMS Holdings Inc
2013
William YoungVertex Pharmaceuticals Incorpor
2014
Adriane BrownAllergan plc
2017
Arthur HigginsEndo International plc
2013
Daniel StarksAbbott Laboratories
2017
Ronald TaylorAllergan plc
2013
David AltshulerVertex Pharmaceuticals Incorpor
2015
Edward LiddyAbbott Laboratories
2010
John LeonardQuintiles IMS Holdings Inc
2015
Louis DrapeauBio Rad Laboratories Inc
2007
Ron TaylorAllergan plc
2013
John StrattonAbbott Laboratories
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Nancy HutsonEndo International plc
2009
W FarrellAbbott Laboratories
2006
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Todd SisitskyQuintiles IMS Holdings Inc
2016
Ari BousbibQuintiles IMS Holdings Inc
2016
Bruce SachsVertex Pharmaceuticals Incorpor
2017
John DanhaklQuintiles IMS Holdings Inc
2016
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Quick Import Now
   

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  Next  Launch Portfolio Quick Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators